Oded Pozis completes the revolution at Novolog: CEO and CFO to step down
Novolog CEO Aviad Bosi and CFO Yaniv Vidavsky will leave their positions in four months. The departure follows the Pozis family's move to secure a 44% controlling stake and replace the board of directors. Oded Pozis is expected to spearhead a new strategic plan for the company.
Oded Pozis, representative of the Pozis family, the controlling shareholder (44%) of the healthcare services and drug distribution company Novolog (74.2, -1.46%), announced that CEO Aviad Bosi and CFO Yaniv Vidavsky will finish their roles in the company.
The company stated that Bosi and Vidavsky reached an agreement with the board of directors on their departure and will remain for a four-month handover period. According to the announcement, Bosi decided to leave his position "for personal reasons and in coordination with the company's chairman, Oded Pozis."
The management change follows recent corporate developments. About two weeks ago, Oded Pozis announced his intention to replace the board of directors. Simultaneously, an offer arrived from Eli Dahan, the controlling shareholder of the Movement group, to invest 100 million shekels to acquire 21% of the company—a move that could have prevented the board replacement and equalized Dahan's influence with that of the Pozis family.
The situation concluded with the Pozis family purchasing the shares of the Arkin and Phoenix groups for 91 million shekels, at a price 45% higher than the market value, reaching a 44% holding. By doing so, the family solidified its control. The board of directors resigned, and Oded Pozis, who took leadership of the family's involvement in May, appointed a new board and named himself chairman.
Claims of harsh conduct
Earlier this year, Udi Pozis sought to sell his stake but failed to find a suitable buyer. He subsequently brought his son Oded into the company. Disagreements quickly arose between Oded Pozis and the former board; the board claimed Pozis conducted himself in harsh tones, while Pozis claimed the board was withholding information.
Novolog, which soared during the pandemic, has faced difficulties in recent years. Write-offs following acquisitions led to a 39 million shekel loss in 2023. In 2025, the company faced a crisis following the replacement of its ERP system (SAP), which disrupted operations for several months. While the company remains profitable and recorded growth in 2025 compared to 2024, there are concerns that the current business mix cannot sustain significant profitability without major changes.
At its peak, the company was valued at 1.8 billion shekels, but following investment write-offs, the valuation has plummeted to 424 million shekels. Bosi and the former board managed to execute only the stage of reducing non-core activity. It now appears that Pozis intends to draft a new strategic plan with a different CEO.
